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Abstract : Endometrial cancer is the seventh most common human malignancy and 
the most common form of cancer treated in women by obstetrics and gynecology 
departments.  Until now, magnetic resonance imaging（MRI） has been used for 
pre-surgical evaluation of endometrial cancer and evaluating the depth of myome-
trial invasion, in addition to being a valuable diagnostic tool.  Diffusion-weighted 
imaging（DWI） has been reported as useful in distinguishing between benign 
and malignant tumors when observing lesions in the endometrium.  Subsequent 
reports suggest that DWI is also effective in identifying malignancy and diagnos-
ing local extension in a range of tissues.  Based on this, we implemented a study 
of the effectiveness of DWI in identifying local extension of endometrial cancer.  
This study enrolled patients undergoing surgery at this hospital for cancer of the 
uterine body during the six years from January 2008 to February 2014.  Cases in 
which images were unclear or the lesions were too small to be described by MRI 
examination were excluded, leaving 61 patients in the study.  Using the results 
from pre-surgical MRI, a sequence comprising a T2-weighted axial view alone 
and a T2-weighted axial view to which a diffusion-weighted axial view had been 
added was created for each patient.  Two radiologists then independently examined 
the image sequence to determine localized extension.  Following surgery, the pre-
surgical assessment was compared to the localized extension determined by histo-
pathology of post-surgical samples to evaluate the effectiveness of adding diffusion-
weighted imaging to the process.  The rst radiographic interpreter’s rate of correct 
diagnosis using the T2-weighted axial view alone was 45 out of 55 cases（81.8％）, 
while using the T2-weighted axial view to which a diffusion-weighted axial view 
had been added gave a correct diagnosis rate of 51 out of 55 cases（92.7％）.  The 
second radiographic interpreter’s rate of correct diagnosis using the T2-weighted 
axial view alone was 41 out of 55 cases（74.5％）, while using the T2-weighted 
axial view with diffusion-weighted axial view added gave a correct diagnosis rate of 
51 out of 55 cases（92.7％）.  These differences were statistically signicant based 
on the McNemar testing.  This study conrmed that DWI is an effective means 
of diagnosing localized extension from images.  It is anticipated that DWI will be  
used in the future clinical workplace to provide more accurate pre-surgical diagnoses.  
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Introduction
　Endometrial cancer is the seventh most common malignancy and the most common form 
of cancer treated in women by obstetrics and gynecology departments 1）.  Furthermore, 
adenocarcinoma originating in the endometrium is becoming more common, with the absolute 
number of cases noticeably increasing in Japan.  Endometrial cancer occurs frequently in women 
in their 50s ; however, while there has been no significant change in the age profile of patients, 
the number of younger patients is increasing 2）. 
　Although a wide range of tumor tissue types can arise from endometrium, most are 
adenocarcinoma, with endometrioid adenocarcinoma being particularly common.  During fiscal 
2007, data from the Japan Society of Obstetrics and Gynecology revealed that 85％ of malignant 
uterine body tumors were endometrioid adenocarcinoma. 
　While prognostic factors in endometrial cancer include uterine factors such as tissue type, dif-
ferentiation, muscle layer penetration, cervical penetration, vascular factors, abnormal endometrial 
hyperplasia, the presence of hormone receptors, DNA ploidy, and S-phase fraction, only the age 
at onset and depth of myometrial invasion are proven independent prognostic factors, indicating 
the importance of diagnosing myometrial invasion 3）. 
　The International Federation of Gynecology and Obstetrics（FIGO） staging and The  TNM 
Classification of Malignant Tumours（TNM） was revised in 2008, and in line with this, the 
classification of surgery and advancement has also been revised 4）.  At the same time, image-
based diagnosis has become more important for diagnosing the clinical stage of uterine body 
cancers. Until now, magnetic resonance imaging（MRI） has been the most accurate method 
of obtaining such image diagnoses for pre-surgical evaluations of endometrial cancer and for 
assessing the depth of myometrial invasion5-7）, and a recent meta-analysis rated contrast-enhanced 
T1-weighted MRI as more effective than ultrasonography, CT, or non-contrast MRI 8）.  However, 
given the risk 9） of nephrogenic systemic fibrosis（NSF） resulting when gadolinium contrast agent 
is administered to patients with renal failure, the demand for non-contrast MRI will rise in the 
future. 
　Diffusion-weighted imaging（DWI） is a type of MRI sequence that captures the diffusion 
movement of water molecules, and is reportedly effective in distinguishing between benign and 
malignant tumors in the endometrium 10）.  Subsequent reports indicate that DWI is also effec-
tive in distinguishing between benign and malignant tumors in various areas, and in identifying 
localized extension11-20）.  We therefore sought to evaluate the effectiveness of DWI in identifying 
localized extension of uterine body cancer. 
Materials and methods
Patients
　Ethical approval for this retrospective study was granted by the institutional review board, and 
patient consent was not required.
　The scope of the study included patients who attended our hospital during the six years from 
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January 2008 to February 2014 and were subjected to T2-enhanced axial view and MRI, includ-
ing DWI, prior to undergoing hysterectomy. 
　In total, 55 patients（average age 59.20 years, range 33—92 years） were registered in the study, 
none of whom had undergone both chemotherapy and radiotherapy prior to surgery. 
MRI examination
　All 55 patients were examined using a SIEMENS-manufactured body coil, of these, 33 had 
images taken using 3.0 TMRI（Magnetom Trio A Tim 3.0T, manufactured by SIEMENS）, 17 
using 1.5 TMRI（Magnetom Avanto 1.5T, manufactured by SIEMENS）, and 5 using 1.5 TMRI
（Magnetom ESSENZA 1.5T, manufactured by SIEMENS）. 
　All patients underwent MRI prior to surgery, with the MR sequences including both 
T2-weighted and diffusion-weighted images. 
　T2-enhanced axial-view images were taken perpendicular to the body of the uterus, using the 
spin echo method, with the following scan parameters : TR / TE 6000-4500 / 103-94 msec ; slice 
thickness 5 mm ; eld of view（FOV） 22 cm ; base resolution 384 ; voxel size 1.0×0.8×5.0 mm 
（3.0T）, 1.1×0.8×5.0 mm（1.5T）. 
　Diffusion-weighted images were taken perpendicular to the body axis, with the following 
scan parameters : TR / TE 4000-3400 / 97-79 msec ; slice thickness 5 mm ; eld of view（FOV） 
35 cm ; voxel size 1.0×0.8×5.0 mm（3.0T）, 1.1×0.8×5.0 mm（1.5T）; b-values 50, 500, 1000, and 
2000 s / mm2. 
　The apparent diffusion coefcient map（ADC map） was automatically created using the manu-
facturer’s software program. 
Image analysis
　The tumor areas showed a higher signal intensity on T2-enhanced images than normal myo-
metrium and a lower signal intensity than normal endometrium in each case.  With DWI and 
the ADC map, tumors showed a higher signal intensity than normal myometrium in each case.  
　The diagnosis of local extension was also compared on T2-enhanced axial-view imaging, DWI, 
and ADC map.  Two radiologists（with 4 and 33 years of experience in image-based diagnosis, 
respectively） independently determined localized extension of the tumors based on the UICC 7th 
edition TNM. 
　The authors compared the results of T categorization using only the T2-enhanced axial view, 
according to the aforementioned categories, with those using the T2-enhanced axial view com-
bined with DWI.  When evaluating the DWI, the doctors also referred to the ADC map as a 
supplemental resource. 
　The authors subsequently compared the results of histopathological testing following hysterec-
tomy, with the diagnosis regarding localized extension determined using each patient’s pre-surgical 
MRI examinations.
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Statistical analysis
　Statistical analysis was implemented using the SPSS version17.0 software program and McNe-
mar testing.  P＜ 0.05 was considered to indicate a signicant difference. 
Results
　Of the 55 patients in this study with endometrioid adenocarcinoma, 41 were T1a and 4 were 
T1b.  The length of the tumors ranged from 12 to 85 mm, with widths of 4-67 mm.
　The rst radiographic interpreter’s rate of correct diagnosis using the T2-weighted axial view 
alone was 45 out of 55 cases（81.8％）, while using the T2-weighted axial view to which a 
diffusion-weighted axial view had been added gave a correct diagnosis rate of 51 out of 55 cases 
（92.7％）.  In ve cases of the T2-enhanced imaging and in two cases of DWI, the images were 
somewhat unclear due to artifact.  In addition, in another ve cases of the T2-enhanced imaging 
and in two cases of DWI, poor image detection due to myoma made them difcult to interpret. 
　The second radiographic interpreter’s rate of correct diagnosis using the T2-weighted axial 
view alone was 41 out of 55 cases（74.5％）, while using the T2-weighted axial view to which 
a diffusion-weighted axial view had been added, gave a correct diagnosis rate of 51 out of 55 
cases（92.7％）. （Table 1）.
　With the T2-enhanced images, seven cases had somewhat unclear images due to artifact, while 
in another six cases, poor image detection due to myoma made the images difcult to interpret, 
and one case showed primary ovarian cancer.  With the DWI, three cases showed somewhat 
unclear images due to artifact, and image interpretation was difcult in one case due to myoma.
　A difference in the radiologist’s experience was thought responsible for the mismatch between 
the rst and second radiographic interpreter. 
Table 1.  Correlation of Histopathological Results in 55 Patients
<50% Invasion
（T1a）（n=41）
≧50% Invasion
（T1b）（n=14）
Accuracy P value
MR Imaging Method 
and Invasion
Reader 1 Reader 2 Reader 1 Reader 2 Reader 1 Reader 2 Reader 1 Reader 2
T2-weighted imaging 81.80% 74.54%
 T1a 34 33 3 5
 T1b 7 8 11 8
 T2  0 0 0 0
 T3a 0 0 0 1
 T3b 0 0 0 0
Fused DWI 92.72% 92.72%
 T1a 39 38 2 1
 T1b 2 3 12 13
 T2  0 0 0 0
 T3a 0 0 0 0
 T3b 0 0 0 0 0.031 0.006
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　The McNemar analysis resulted in P values of 0.031 and 0.006 for the rst and second radio-
graphic interpreters, respectively.  Both of these were below 0.05, within the range of signicant 
difference. 
Discussion
　Evaluating the stage of advancement of endometrial cancer is mainly carried out based on 
T2-enhanced imaging results ; however, using only these images makes accurate evaluation dif-
cult in many cases, necessitating the additional use of contrast MRI.  In the case of local exten-
sion, the reported rate of accurate diagnosis of myometrial invasion is 58～77％ 21-23）. 
　Many studies reported a signicant improvement in the ability to diagnose myometrial invasion 
based on MRI results compared to T2-enhanced images alone.  In particular, a contrast dynamic 
study is highly effective, improving accuracy signicantly from 58～77％ with T2-enhanced images 
alone to 85～93％ 21-24）.  However, despite this improvement, it is believed that allergies to 
contrast agents and the fact that contrast agents cannot be used in patients with compromised 
renal function will mean that, in the future, it will become more important to implement pre-
surgical diagnosis of endometrial cancer using non-contrast MRI, along with diagnosing localized 
extension prior to surgery using basic MRI technology.  Accordingly, the use of DWI in pre-
surgical evaluation provides an important supplementary sequence in the accurate diagnosis of 
endometrial cancer. 
　MRI DWI provides roughly the same level of diagnostic ability as contrast MRI, and in many 
cases, it further enables the evaluation of tumor spread.  However, according to the studies of 
Rechichi et al 25）, DWI was more effective when a comparison was implemented using 1.5 TMRI 
between DWI and contrast MRI. 
　In this study, endometrial cancer demonstrated higher signal intensity on DWI than normal 
endometrium, and the addition of diffusion-weighted imaging to the T2-enhanced axial view 
further improved the rate of accurate diagnosis.  Thus, the present study clearly demonstrated the 
effectiveness of adding DWI to the T2-enhanced axial view. 
　This study also revealed a case in which a mistaken evaluation of myometrial invasion in 
the periphery of the tumor led to a misevaluation of local extension using T2-enhanced images 
（Fig. 1）.  This was attributed to the fact that the signal-intensity difference between the tumor 
and normal muscle layer was unclear because of artifacts in the periphery of the tumor.  Since 
the use of DWI together with the ADC map provides better, clearer contrast between the tumor 
and normal muscle layer than T2-enhanced images, it would contribute to a correct diagnosis. 
　Accurate evaluation of myometrial invasion is known to be difcult for cases in which the 
tumors are large polyps and for cases complicated by uterine leiomyoma, uterine deformities, or 
a small uterus 26）. 
　The present study also revealed one case among those complicated by uterine leiomyoma that 
was mistakenly diagnosed as local extension based on the T2-enhanced axial view alone （Fig. 2）. 
　In this case, myoma was noted within the muscle layer on the cranial side of the tumor, and it is 
believed that the boundary between the myoma and tumor was unclear in the T2-enhanced axial view. 
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　Furthermore, in cases complicated by adenomyosis, in which the tumor and the adenomyosis 
are connected, it is not possible to obtain visible contrast between the normal uterine muscle 
layer and the myoma, and this is considered to reduce diagnostic ability with regard to myome-
trial invasion 27）.  In the past, the combined use of T2-enhanced images with DWI, using a 3T 
MRI, has allowed correct evaluation of myometrial invasion in cases complicated by adenomyosis 
and other factors that make the evaluation difcult 28）. 
　In this study, the T2-enhanced axial views were further taken perpendicular to the body of the 
uterus, while diffusion-weighted images were taken perpendicular to the trunk of the body.  As a 
result, the cross-section of the two images was found to be different, making it difcult to arrive 
at a correct evaluation of local extension in the periphery of the tumor.  Thus, we recommend 
ensuring that both T2-enhanced and diffusion-weighted images are taken using the same slice 
when assessing local extension. 
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Fig. 1.  40-year-old woman
The authors discovered a case in which a mistaken evaluation of myometrial invasion 
in the periphery of the tumor（➡） led to a misevaluation of local extension using 
T2 enhanced images. The T2 enhanced axial view （a）of the left side of the uterine 
body does not clearly show the boundary between the myoma（▶） and the uterine 
muscle layer, while diffusion-weighted imaging（DWI）（b）and ADCmap （c） show 
a clear contrast. In this case, the patient was diagnosed as T1b when using the 
T2 enhanced axial view alone, but determined to be T1a when diffusion-weighted 
imaging was added, which was consistent with the pathological findings. 
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